Top Banner
Page 0 xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Tumors and Malformations Perinatal Management Christopher Cassady MD Edward B. Singleton Department of Pediatric Radiology Texas Children’s Hospital [email protected]
39

Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Apr 10, 2019

Download

Documents

trinhkhanh
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 0

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Tumors and

Malformations Perinatal Management

Christopher Cassady MD

Edward B. Singleton Department of Pediatric Radiology Texas Children’s Hospital

[email protected]

Page 2: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 1

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

We will discuss both

•Diagnostic Options

•Therapeutic Options

Page 3: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 2

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Diagnostic Options

Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA* TUFTED ANGIOMA*

Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION VENOUS MALFORMATION VENOCAPILLARY MALFORMATION

Page 4: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 3

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Diagnostic Options

Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*

Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION

These are the diagnostic options for an imager in the perinatal period

Page 5: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 4

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Why treat? Location: airway, compartment syndrome Shunting/heart failure Shunting/venous hypertension/ischemia Consumptive coagulopathy Hypothyroidism Cosmetic, including ulceration/bleeding

Page 6: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 5

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Medical therapy Steroids Beta blockers Antiangiogenics Chemotherapy Endovascular therapy (embolization)/sclerotherapy Surgery Tincture of Time

Page 7: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 6

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Diagnostic Options

Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*

Page 8: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 7

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Glut 1 negative

•RICH: present at birth, involutes by 12-14 months of age •NICH: present at birth, no regression

Glut 1 positive

•Common Infantile: appears in infancy, proliferative/degenerative •Benign Neonatal Hemangiomatosis •Disseminated NH •PHACES

HEMANGIOMA

Page 9: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 8

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

HEMANGIOMA

Glut 1 negative CONSERVATIVE Treat ulcerations with local wound care STEROIDS if high output symptoms: EMBOLIZE or EXCISE

Glut 1 positive CONSERVATIVE PROPRANOLOL STEROIDS THYROXINE as necessary surgery, laser, cryoablation, chemotherapy if desperate

Page 10: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 9

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

CONGENITAL HEMANGIOMA

Page 11: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 10

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

CONGENITAL HEMANGIOMA

Page 12: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 11

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LIVER LESIONS

Lesions can be called solitary hemangioma, diffuse hemangiomatosis, hemangioendothelioma, or hepatic vascular malformation with capillary proliferation.

CONFUSING

Page 13: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 12

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LIVER LESIONS

BOSTON group: •Focal

•Behaves like a RI Congenital Hemangioma (Glut 1 -) •Usually asymptomatic; monitor for shunting

•Multifocal or Diffuse •Glut 1 +, behave like Infantile Hemangioma

•Multifocal: AV or PV shunting *HO Failure* •Diffuse: Abd Compartment Syndrome, hypothyroid

*LO Failure*

Page 14: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 13

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

FOCAL HEMANGIOMA

Page 15: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 14

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

FOCAL HEMANGIOMA

Page 16: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 15

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

FOCAL HEMANGIOMA

Page 17: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 16

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

FOCAL HEMANGIOMA

Page 18: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 17

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

DIFFUSE HEMANGIOMA

Page 19: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 18

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Algorithm from Boston

Page 20: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 19

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

CONGENITAL HEMANGIOMA

Page 21: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 20

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

KAPOSIFORM HEMANGIOENDOTHELIOMA

Page 22: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 21

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

KAPOSIFORM HEMANGIOENDOTHELIOMA

Page 23: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 22

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

KAPOSIFORM HEMANGIOENDOTHELIOMA

•Systemic corticosteroids

•Alpha interferon

•AntiAngiogenics

•Multimodal intervention

•Surgery: not generally first-line because of infiltration

Page 24: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 23

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Diagnostic Options

Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA KAPOSIFORM HEMANGIOENDOTHELIOMA*

Congenital Vascular Malformations AVM/AVF LYMPHATIC MALFORMATION

Page 25: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 24

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

AVM/AVF

Page 26: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 25

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

AVM/AVF

Page 27: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 26

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

PORTOSYSTEMIC FISTULA

Congenital arterioportal fistulae •Present as neonates with FTT and abdominal distension from splenomegaly, +/- GI bleeding •enlarged hepatic artery with dilation of the PV at the fistula, pulsatile hepatofugal flow in PV •Treated angiographically with coil/particle embolization

Page 28: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 27

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LIVER LESIONS

Page 29: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 28

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LIVER LESIONS

Page 30: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 29

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Patent Ductus Venosus

Page 31: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 30

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

Patent Ductus Venosus

Page 32: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 31

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Lesions that require treatment for location typically get a combination of •Surgery (debulking)

•Intralesional sclerotherapy with

•Doxycycline •Bleomycin •OK432 •STS+ (EtOH or doxycycline)

Page 33: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 32

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Page 34: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 33

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Page 35: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 34

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Page 36: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 35

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Page 37: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 36

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Therapeutic Options

LYMPHATIC MALFORMATIONS

Page 38: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 37

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

Diagnostic with Therapeutic Options

Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA Glut 1 - : Nothing, or steroids Glut 1+ : Nothing, or propranolol KAPOSIFORM HEMANGIOENDOTHELIOMA Steroids, Multimodality therapy

Congenital Vascular Malformations AVM/AVF Endovascular therapy LYMPHATIC MALFORMATION Sclerotherapy +/- surgery

Page 39: Vascular Tumors and Malformations - pedrad.org · xxx00.#####.ppt 12/4/2012 3:05:55 PM Vascular Lesion Management Diagnostic Options Congenital Vascular Neoplasms CONGENITAL HEMANGIOMA

Page 38

xxx00.#####.ppt 12/4/2012 3:05:55 PM

Vascular Lesion Management

SELECTED REFERENCES

Christison-Lagay, ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement J, Mulliken JB, Fishman SJ. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Ped Surg 2007; 42: 62-68.

Solomon T, Ninnis J, Deming D, Merritt TA, Hopper A. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 2011 Nov;31(11):739-41

Lawley LP, Siegfried E, Todd JL.. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009 Sep-Oct;26(5):610-4.

Teplisky D, Tincani EU, Lipsich J, Sierre S. Congenital arteriportal fistulas: radiologic treatment and color Doppler US follow up. Pediatrr Radiol 2012 Nov ;42(11): 1326-1332.